Earnings Call · Q3 FY2021·2021-11-09

Q3 21EPS -15.65%·Rev n/aQ2 21EPS -26.87%·Rev n/aQ1 21EPS -13.21%·Rev n/aQ4 20EPS +17.86%·Rev n/a⚠ consensus missing

Lyra Therapeutics, Inc. LYRA

Stephanie Marks — Conference Call Host

Maria Palasis — President and Chief Executive Officer

Robert Kern — Chief Medical Officer

Jason Cavalier — Chief Financial Officer

−3.7%1d on move date−3.4% vs SPY3d−0.1%5d+1.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LYRA calls or request research access.

More LYRA calls Browse calls Request research access